Division of Translational Cancer Research
201 – 210 of 599
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Anti-tumor effects of rigosertib in high-risk neuroblastoma
(
- Contribution to journal › Article
-
Mark
Quantification of microRNA editing using two-tailed RT-qPCR for improved biomarker discovery
(
- Contribution to journal › Article
-
Mark
Sulfidic anoxia in the oceans during the Late Ordovician mass extinctions – insights from molybdenum and uranium isotopic global redox proxies
(
- Contribution to journal › Scientific review
-
Mark
Machine learning in the prediction of cancer therapy
(
- Contribution to journal › Scientific review
-
Mark
In vitro nephrotoxicity studies of established and experimental platinum-based compounds
(
- Contribution to journal › Article
- 2020
-
Mark
Integrative discovery of treatments for high-risk neuroblastoma
(
- Contribution to journal › Article
-
Mark
Abstract P1-18-10: Preoperative treatment of HER2-positive breast cancer in South Sweden. A retrospective, comprehensive survey of neo-adjuvant treated HER2-positve breast cancer in the SCAN-B project 2010-2017
2020) San Antonio Breast Cancer Symposium, 2019 In Cancer research. Supplement 80(Issue 4 Supplement). p.1-18(
- Contribution to journal › Published meeting abstract
-
Mark
Why and how to investigate the role of protein phosphorylation in ZIP and ZnT zinc transporter activity and regulation
(
- Contribution to journal › Scientific review
-
Mark
The STRIPAK Complex Regulates Response to Chemotherapy Through p21 and p27
(
- Contribution to journal › Article
-
Mark
Whole-genome sequencing of triple negative breast cancers in a standard population-based clinical setting
2020) UK Interdisciplinary Breast Cancer Symposium 2020 In Breast Cancer Research and Treatment 180. p.531-532(
- Contribution to journal › Published meeting abstract